Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

A decades-long study of Danish conscripts finds that despite the rise in obesity, the inverse relationship between intelligence and BMI has remained unchanged.

Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on whether ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

Appalachia has a rich history and gorgeous landscapes, but it has also experienced rates of cancer incidence and death ...

Community advocate Dave Letele – whose latest TV show screens on Thursday highlighting New Zealand’s obesity epidemic – is ...

Big pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions, and more ...

The Philadelphia Eagles won Super Bowl LIX on Sunday, defeating the Kansas City 40-22. The 2025 Super Bowl commercial lineup ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 10 includes Advanced Micro Devices, Novo Nordisk ...

Community advocate Dave Letele – whose latest TV show screens on Thursday highlighting New Zealand’s obesity epidemic – is ...

A deep learning tool developed by researchers from MIT and Harvard Medical School shows promise in predicting heart failure ...